Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabrafenib, Trametinib, and Metformin in BRAF V600E+ Melanoma
NCT02143050Phase 2Withdrawn
- Sponsor
- University of Louisville
- Start
- Sep 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in melanoma, sponsored by University of Louisville. Planned start Sep 2014; status: withdrawn.
02
Drugs
metformin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02143050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02143050.